HomeAI · summaries
Storia in 4 fonti
Teplizumab Approval Expands to Early Type 1 Diabetes
Product aims to disrupt the autoimmune attack against insulin-producing beta cells
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Breakthrough T1D Celebrates Approval of Tzield for use in Stage 3 Type 1 Diabetes in the US
Breakthrough T1D Celebrates Approval of Tzield for use in Stage 3 Type 1 Diabetes in the US
- ·
healio.com
FDA approves Tzield to treat children and adolescents with stage 3 type 1 diabetes
The FDA has granted accelerated approval for teplizumab-mzwv as the first disease-modifying therapy for children and adolescents with stage 3 type 1 diabetes, according to an…
